Issue information : J Pediatr. 2017 Jun;185:49-54.e2. doi: 10.1016/j.jpeds.2017.02.061
Co-author : So Yoon Ahn, Yun Sil Chang, Ji Hye Kim, Se In Sung, Won Soon Park
Link : https://pubmed.ncbi.nlm.nih.gov/28341525/
Intratracheal transplantation of PNEMOSTEM in preterm infants enrolled in the Phase I Trial has been shown to be safe, with no adverse respiratory, growth, and neurodevelopmental effects at 2 years follow-up.
